Enables standardized inpatient hospital billing for QUELIMMUNE ® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER ...

Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. I have written in March about Google’s TurboQuant for compressing data in memory for AI ...

Fulcrum Therapeutics has scrapped its sole clinical-stage program after the FDA took a hard line on the modality following the recent withdrawal of Ipsen’s Tazverik from the U.S. market. Ipsen ...

SCD, a global leader in defense technology specializing in the development and manufacture of a wide range of cooled and uncooled infrared detectors and high-power laser diodes, announces significant ...

Capital One reported disappointing first-quarter results, as poor loan growth and sequential net interest margin compression were headwinds to net interest income. Diluted earnings per share fell to ...

Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset reduced a painful complication of sickle cell disease (SCD) in a phase 3 study.

Accessories are often the most fun part of getting dressed. A great bag, a pair of statement earrings, or the right sunglasses can transform an entire outfit. Designer Destiny Pinto believes that same ...

In collaboration with distributor Master Medical Equipment (MME), Defibtech announced the availability of flexible leasing options for their ARM XR Automated Chest Compression device. The new ...

When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. If you’ve ever taken a long ...

Puccio provided guidance for Q2, stating, "Revenue is expected to be $3.5 billion, plus or minus $100 million. Operating margin at the midpoint is expected to be 47.5%, plus or minus 100 basis points.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...